host

Better Choice Company to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 27th at 4:30 p.m. ETBetter Choice Company to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 27th at 4:30 p.m. ET

Better Choice Company to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 27th at 4:30 p.m. ET

March 07, 2025 17:30 ET  | Source: Better Choice Company Inc. TAMPA, Fla., March 07, 2025 (GLOBE NEWSWIRE) -- Better…

2 months ago
Global-e to Host 2025 Investor DayGlobal-e to Host 2025 Investor Day

Global-e to Host 2025 Investor Day

March 06, 2025 16:05 ET  | Source: Global-e Online Ltd PETAH-TIKVA, Israel, March 06, 2025 (GLOBE NEWSWIRE) -- Global-e (Nasdaq:…

2 months ago
CEPT University to Host Urban Planning Masterclass in New Delhi on March 11 & 12CEPT University to Host Urban Planning Masterclass in New Delhi on March 11 & 12

CEPT University to Host Urban Planning Masterclass in New Delhi on March 11 & 12

AHMEDABAD, India, March 4, 2025 /PRNewswire/ -- CEPT University will host a three-part masterclass series on critical aspects of urban…

2 months ago
Apogee Therapeutics to Host Conference Call to Report Interim Results from the Phase 1 Healthy Volunteer Trial for APG990 and Provide Combination Strategy Update on March 3, 2025Apogee Therapeutics to Host Conference Call to Report Interim Results from the Phase 1 Healthy Volunteer Trial for APG990 and Provide Combination Strategy Update on March 3, 2025

Apogee Therapeutics to Host Conference Call to Report Interim Results from the Phase 1 Healthy Volunteer Trial for APG990 and Provide Combination Strategy Update on March 3, 2025

SAN FRANCISCO and BOSTON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing…

2 months ago
Toronto to Host EmpowerHER Womens Health Summit on March 1, 2025: Uniting Top Experts for Transformative ChangeToronto to Host EmpowerHER Womens Health Summit on March 1, 2025: Uniting Top Experts for Transformative Change

Toronto to Host EmpowerHER Womens Health Summit on March 1, 2025: Uniting Top Experts for Transformative Change

TORONTO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- The 1st Annual EmpowerHER Women’s Health Summit, hosted by Bridge Medical Communications, will…

2 months ago
FOUR COUNTRIES SHORTLISTED TO HOST THE GAMES OF THE FUTURE 2027FOUR COUNTRIES SHORTLISTED TO HOST THE GAMES OF THE FUTURE 2027

FOUR COUNTRIES SHORTLISTED TO HOST THE GAMES OF THE FUTURE 2027

Brazil, Serbia, South Africa, and Uzbekistan in the race to host the global phygital sports event DUBAI, UAE, Feb. 25,…

2 months ago
Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn’s and Colitis Organisation (ECCO)Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn’s and Colitis Organisation (ECCO)

Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn’s and Colitis Organisation (ECCO)

February 18, 2025 16:30 ET  | Source: Teva Pharmaceutical Industries Ltd TEL AVIV, Israel, Feb. 18, 2025 (GLOBE NEWSWIRE) --…

2 months ago
AVITA Medical to Host Investor Webinar BriefingAVITA Medical to Host Investor Webinar Briefing

AVITA Medical to Host Investor Webinar Briefing

VALENCIA, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound…

2 months ago
ENA Respiratory Receives US$5m Investment from Flu Lab to Support Clinical Development of Novel Intranasal Antiviral Host Defence Immune Enhancer, INNA-051ENA Respiratory Receives US$5m Investment from Flu Lab to Support Clinical Development of Novel Intranasal Antiviral Host Defence Immune Enhancer, INNA-051

ENA Respiratory Receives US$5m Investment from Flu Lab to Support Clinical Development of Novel Intranasal Antiviral Host Defence Immune Enhancer, INNA-051

MELBOURNE, Australia, Feb. 10, 2025 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence immune enhancers…

2 months ago
Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2024 Financial Results and Corporate UpdateUltragenyx to Host Conference Call for Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update

Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update

February 06, 2025 16:30 ET  | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical…

3 months ago
Show more Posts
Show previous Posts